Ignite Creation Date:
2025-12-24 @ 4:17 PM
Ignite Modification Date:
2026-01-01 @ 9:44 AM
Study NCT ID:
NCT04512066
Status:
COMPLETED
Last Update Posted:
2023-10-10
First Post:
2020-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-12
First Submit QC Date:
None
Study First Post Date:
2020-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-16
Results First Submit QC Date:
None
Results First Post Date:
2023-10-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-15
Last Update Post Date:
2023-10-10
Last Update Post Date Type:
ACTUAL